retatrutide ly3437943 triple agonist glp-1 gip glucagon mechanism Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Beyond GLP-1: Retatrutide's triple-agonist mechanism

Myint AS, Rieders B, Tashkandi M, et al

But the triple mechanism intensifies some of these effects compared to what semaglutide and tirzepatide side effects look like individually

How do GLP-1 injections work in the body

The market is projected to reach a valuation of 42.0 USD Billion by 2035

Liraglutide, semaglutide and dulaglutide have demonstrated cardiovascular benefits, and Wegovy recently added to this evidence base: in the SELECT trial, patients on Wegovy had a 20% lower incidence of heart attack, stroke or death from heart disease compared to those on a placebo

You might be experiencing side effects that dont get better or your insurance might cover one and not another, for example